Format

Send to

Choose Destination
J Med Chem. 2009 Nov 12;52(21):6790-802. doi: 10.1021/jm900648x.

Hydroxamates: relationships between structure and plasma stability.

Author information

1
INSERM U761 Biostructures and Drug Discovery, Univ Lille Nord de France, Lille F-59006, France.

Abstract

Hydroxamates are valuable tools for chemical biology as well as interesting leads for medicinal chemistry. Although many hydroxamates display nanomolar activities against metalloproteases, only three hydroxamates have reached the market, among which is the HDAC inhibitor vorinostat. Failures in development are generally attributed to lack of selectivity, toxicity, or poor stability. To help medicinal chemists with respect to plasma stability, we have performed the first and preliminary study on structure-plasma stability for hydroxamates. We define some structural rules to predict or improve the plasma stability in the preclinical stage.

PMID:
19821586
DOI:
10.1021/jm900648x
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for American Chemical Society
Loading ...
Support Center